...
首页> 外文期刊>Journal of International Medical Research >Validation of circulating BNP level >1000?pg/ml in all-cause mortality: A retrospective study
【24h】

Validation of circulating BNP level >1000?pg/ml in all-cause mortality: A retrospective study

机译:一项回顾性研究验证循环血BNP水平> 1000?pg / ml在全因死亡率中

获取原文
           

摘要

Aim To determine the primary diseases and prognoses of patients with highly elevated levels of B-type natriuretic peptide (BNP; >1000?pg/ml), with or without heart failure. Methods Medical records and echocardiograms of patients with BNP levels that fell within one of three predetermined categories (>1000?pg/ml, 200–1000?pg/ml and 1000?pg/ml (n?=?103) or 200–1000?pg/ml (n?=?100) had significantly worse 3-year survival than those with BNP levels 1000?pg/ml group had heart failure. The main cause of death in patients with other causes of BNP levels >1000?pg/ml (39/103) was community acquired pneumonia. Conclusion A BNP level >1000?pg/ml has clinical importance in primary care medicine and hospital settings.
机译:目的确定患有或不患有心力衰竭的B型利钠肽(BNP;> 1000µpg / ml)水平高的患者的原发疾病和预后。方法BNP水平属于三个预定类别(> 1000?pg / ml,200–1000?pg / ml和1000?pg / ml(n?=?103)或200–1000)之一的患者的病历和超声心动图βpg/ ml(n?=?100)的3年生存率显着低于BNP水平为1000?pg / ml组的心衰;其他原因导致的BNP水平> 1000?pg的患者死亡的主要原因/ ml(39/103)是社区获得性肺炎结论结论BNP> 1000?pg / ml在临床医疗和医院环境中具有重要的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号